Coronavirus: German/US vaccine candidate cleared for Phase 2 and 3 clinical trials

Pfizer, BioNTech start their COVID-19 vax phase 3, squaring off with Moderna

Upstate Medical injecting people with experimental Covid-19 vaccine for global study

The trial's primary endpoints will be prevention of COVID-19 in those who have not been infected by SARS-CoV-2 as well as the prevention of COVID-19 regardless of whether they have previously had the virus. That means some participants will receive a placebo and others, the potential vaccine.

Poonawalla has also said that the company would reserve around half the vaccines it produces for India.

Moderna Inc.'s vaccine candidate against Covid-19 protected against the virus in a trial that inoculated 16 monkeys, an encouraging step on the path to a defense for humans against the pandemic.

A vaccine is the golden ticket back to normality, and is eagerly sought by people throughout the world.

In stressing the impetus for the investigation, the university notes COVID-19's global spread - it has infected 16.8 million internationally, 4.4 million in the United States, and almost 43,200 people in Iowa, to date.

Mitt Romney proposes compromise on logjammed pandemic aid
It would provide another round of $1,200 direct payments based on the same formula from the earlier aid bill. Susan Collins, R-Maine, cosponsored the legislation with Romney, and said it is a reasonable compromise.


"We have received vaccine for a portion of the subjects who will be enrolled at Iowa and additional doses will be shipped as we use up our initial allocated stock", Winokur said.

Even if phase 3 of the trial is completely successful, the researchers said the timeline for a finished vaccine is still unclear. Nasal swabs to test for Covid-19 will also be collected during these times.

Vector is working on six different potential COVID-19 vaccines, World Health Organisation (WHO) records show.

The government has dedicated $37m to the Covid-19 vaccine strategy, which includes support for local research and manufacturing, and support for global research.

The NCSC said it believes the attacks were done with the intent of stealing information and intellectual property related to COVID-19 vaccine research.

Oprah Winfrey Pays Tribute to Breonna Taylor With Historic Magazine Cover
The image was re-created using a widely circulated social media photo of Taylor shared after her death. Oprah Winfrey's "cry for justice" for Breonna Taylor has taken the form of a historic magazine cover.


The National Institutes of Health this week announced the start of the country's first large clinical trial to investigate a COVID-19 vaccine - codeveloped by biotechnology company Moderna, Inc., and the National Institute of Allergy and Infectious Diseases.

The New England Journal of Medicine published a report on the vaccine regarding its earlier testing and indicated that though individuals experienced mild side effects such as fatigue, chills, headache, myalgia, as well as pain experienced in the area where the vaccine was injected, the vaccine was considered as safe.

In a separate development last week, the U.S. federal government reportedly earmarked a whopping $1.95 billion for 100 million doses of the coronavirus vaccine being developed by Pfizer and BioNTech, with an option to buy up to 500 million more doses at a later date.

"Today, we are starting our late-stage global study, which will include up to 30,000 participants", said Biontech CEO Ugur Sahin.

"This is basically an instruction manual" for the immune system, he said.

Covid-19: Moderna's Vaccine Could Cost Between $50 and $60
For this study, the company will enroll 30,000 participants from 39 US states as well as from Germany, Argentina, and Brazil. On July 22, Pfizer and BioNTech said the USA government placed an initial order of 100 million doses for $1.95 billion.


Latest News